Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
03/08/1994 | US5292516 Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers |
03/08/1994 | CA1327523C Antigen immunogenicity |
03/03/1994 | WO1994004702A2 Improved detection and therapy of lesions with biotin/avidin conjugates |
03/03/1994 | WO1994004696A1 Translocation signal facilitated nuclear delivery of macromolecules |
03/03/1994 | WO1994004686A1 Tat-derived transport polypeptides |
03/03/1994 | WO1994004614A1 Metal-mediated cross-coupling with ring-metalated porphyrins |
03/03/1994 | WO1994004593A1 Polyarylates containing derivatives of the natural amino acid l-tyrosine |
03/03/1994 | WO1994004382A1 Timing valve for the discontinuous metering of a volume flow |
03/03/1994 | WO1994004261A1 Utilization of a transacylation reaction between an esterified polysaccharide and a polyaminated or polyhydroxylated substance for fabricating microparticles, microparticles thus obtained, methods and compositions containing them |
03/03/1994 | WO1994004195A1 Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines |
03/03/1994 | WO1994004193A1 Novel attachment of polyalkylene oxides to bio-effecting substances |
03/03/1994 | WO1994004192A1 Method for binding to polymers |
03/03/1994 | WO1994004191A1 Medical treatment |
03/03/1994 | WO1994004138A1 Sustained release tablets containing bupropion |
03/03/1994 | WO1994004134A1 Ophthalmological preparation |
03/03/1994 | WO1994004133A1 Inhalation powder containing antistatic agent |
03/03/1994 | WO1993023550A3 Activation of oligomerizing receptors by using fused receptor ligands |
03/03/1994 | WO1993015205A3 Synthetic haemophilus influenzae conjugate vaccine |
03/03/1994 | DE4328329A1 Freeze-dried polysaccharide bio-matrix useful as pharmaceutical or cosmetic carrier - comprises mixt. of natural and modified material e.g. pectin, alginate, agar, cellulose ether deriv. etc. |
03/03/1994 | DE4229050A1 New esters and amides of 9-chloro-prostaglandins - useful, e.g., in treatment of glaucoma and as diuretic agents |
03/03/1994 | DE4229048A1 New ester(s) of 9-chloro-prostaglandin(s) - useful in treatment of glaucoma and as diuretic agents |
03/03/1994 | DE4228926A1 Spritzfertige Azosemid-Injektionslösungen Spray Ready azosemide injection solutions |
03/03/1994 | DE4228552A1 Diphosphonsäuren und deren Salze enthaltende Arzneimittel Diphosphonic acids and their salts, pharmaceutical compositions containing them |
03/03/1994 | DE4228106A1 Tumour diagnosis and treatment in organs, esp. urinary system - comprises admin. of gamma-amino-levulinic acid as photosensitiser, detection, and treatment by irradiation with neodymium-yttrium-aluminium-garnet laser |
03/03/1994 | CA2143308A1 Translocation signal facilitated nuclear delivery of macromolecules |
03/03/1994 | CA2142961A1 Utilization of a transacylation reaction between an esterified polysaccharide and a polyaminated or polyhydroxylated substance for fabricating microparticles, microparticles thus obtained, methods and compositions containing th m |
03/03/1994 | CA2142884A1 Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines |
03/03/1994 | CA2142881A1 Detection and therapy of lesions with biotin/avidin conjugates |
03/03/1994 | CA2142817A1 Ophthalmological preparation |
03/02/1994 | EP0585151A1 Process to prepare micropheres for the sustained release of LHRH-hormone, microspheres and so-obtained compositions |
03/02/1994 | EP0584876A2 Low diol polyalkylene oxide biologically active proteinaceous substances |
03/02/1994 | EP0584588A1 Anti-ulcer composition containing imidazole derivative |
03/02/1994 | EP0584558A2 A composition for suppressing infection and growth of human immunodeficiency virus using an iron-binding protein |
03/02/1994 | EP0584552A2 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
03/02/1994 | EP0584315A1 Cosmetic and/or pharmaceutical composition containing a dispersion of lipidic vesicles, process for the preparation of said dispersion, and lipidic vesicle dispersion. |
03/02/1994 | EP0584279A1 Targeted delivery of genes encoding immunogenic proteins |
03/02/1994 | EP0584251A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth |
03/02/1994 | EP0584247A1 Compositons for the treatment of chronic fatigue syndrome |
03/02/1994 | EP0584118A1 New conjugates, consisting of a glycoprotein and a nucleic acid-binding substance |
03/02/1994 | EP0514406B1 Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances |
03/02/1994 | EP0509042B1 Pharmaceutical preparation of 1-Octadecyl-2-methyl-glycero-3-phosphocholin for intravenous administration |
03/02/1994 | EP0458929B1 SOLUBILIZATION OF t-PA |
03/02/1994 | EP0423244B1 Tumor necrosis factor formulations |
03/02/1994 | EP0402378B1 Conjugation of polymer to colony stimulating factor-1 |
03/02/1994 | EP0386106B1 Gamma interferon formulation |
03/02/1994 | EP0357665B1 Rapidly dissoluble medicinal dosage unit and method of manufacture |
03/02/1994 | EP0266419B1 Fibrinolytic composition |
03/02/1994 | CN1082924A Microparticle, manufacture of same and application in diagnosis |
03/01/1994 | US5290774 Boric acid and polyhydric alcohol |
03/01/1994 | US5290769 Applying compositions for skin disorders |
03/01/1994 | US5290692 Calcium titanium phosphate glass with sodium oxide and fibrinolytic enzymes for conversion of plasminogen to plasmin bonded to the glass |
03/01/1994 | US5290570 Cellulose powder in lotions with liquids |
03/01/1994 | US5290569 Coated composition and its preparation process |
03/01/1994 | US5290561 Patch of room temperature vulcanizable organopolysiloxane rubber, albuterol, diffusion enhancer of normal hydrocarbon alcohol |
03/01/1994 | US5290560 Extrusion of an admixture of a meltable binder and a food or drug |
03/01/1994 | US5290559 Device and method for treatment of infections |
03/01/1994 | CA2007462C Dispensing devices powered by lyotropic liquid crystals |
03/01/1994 | CA1327354C Anti-inflamatory compounds and compositions |
03/01/1994 | CA1327329C Recombinant diphtheria toxin fragments |
02/28/1994 | CA2104890A1 Chain-terminated n-vinyl lactam polymers and graft-copolymers and methods for making same |
02/28/1994 | CA2101361A1 Low diol polyalkylene oxide biologically active proteinaceous substances |
02/23/1994 | EP0584034A2 Cytotoxic drug conjugates for treatment of neoplastic diseases |
02/23/1994 | EP0583976A2 Gastroprotective complexes with cyclodextrin |
02/23/1994 | EP0583955A2 Physical trapping type polymeric micelle drug preparation |
02/23/1994 | EP0583794A1 Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects |
02/23/1994 | EP0583651A1 Compositions having a physiological cooling effect and suitable compounds for these compositions |
02/23/1994 | EP0583459A1 Cosmetic or dermatological composition in the form of an oil-in-water dispersion capable of forming composite films. |
02/23/1994 | EP0583413A1 Stabilized, aqueous, film-forming antimicrobial compositions of hydrogen peroxide |
02/23/1994 | EP0583399A1 Taste-masked medicaments and their preparation |
02/23/1994 | EP0583389A1 Free amine benzophenanthridine alkaloid compositions |
02/23/1994 | EP0583378A1 Combined calcium and vitamin d supplements |
02/23/1994 | EP0477274B1 FACTOR Xa BASED ANTICOAGULANT COMPOSITIONS |
02/23/1994 | CN1082402A Medicine paste troche |
02/22/1994 | US5288855 Extracellular form of the human fibroblast growth factor receptor |
02/22/1994 | US5288734 Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one and process for producing the same |
02/22/1994 | US5288517 Method of forming planar membrane |
02/22/1994 | US5288502 Drug delivery |
02/22/1994 | US5288493 Skin care compositions with improved rub-off resistance |
02/22/1994 | US5288487 Human monocyte-macrophage-CSF preparations |
02/22/1994 | US5288486 Adding viscosify agent;lowering evaporation |
02/22/1994 | US5288479 Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof |
02/22/1994 | US5288477 Method for prognosticating response to cancer therapy |
02/22/1994 | CA1327164C Film coated ranitidine hydrochloride tablet |
02/22/1994 | CA1327161C Lyophilized pharmaceutical composition of neocarzinostatin derivative |
02/21/1994 | CA2101809A1 Cytotoxic drug conjugates for treatment of neoplastic diseases |
02/18/1994 | CA2103511A1 Gastroprotective complexes |
02/17/1994 | WO1994003610A2 Isolation and cloning of a protein with tyrosine-phosphatase activity |
02/17/1994 | WO1994003527A1 Copolymers of polyaspartic acid |
02/17/1994 | WO1994003499A1 Auto-cross-linked gellan gum |
02/17/1994 | WO1994003468A1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems |
02/17/1994 | WO1994003424A1 Compound capable of intracerebral residence and use thereof |
02/17/1994 | WO1994003198A1 Human growth hormone aqueous formulation |
02/17/1994 | WO1994003191A1 NON-PEPTIDYL MOIETY-CONJUGATED CD4-GAMMA2 AND CD4-IgG2 IMMUNOCONJUGATES, AND USES THEREOF |
02/17/1994 | WO1994003190A1 Topical composition |
02/17/1994 | WO1994003187A1 Sugar-free dry mix cellulose ether compositions as bulk laxatives |
02/17/1994 | WO1994003186A1 Vaginal mucoadhesive gel, medicament containing it and its method of preparation |
02/17/1994 | WO1994003179A1 Crystalline amifostine compositions and methods for the preparation and use of same |
02/17/1994 | WO1994003158A1 Solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
02/17/1994 | WO1994003156A1 Pharmaceutical and/or cosmetic preparation and the use of the preparation |
02/17/1994 | WO1994003155A1 Hydrogel compositions and methods of use |